Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue
- 13 May 2013
- journal article
- Published by Elsevier in Toxicology in Vitro
- Vol. 27 (6) , 1753-1761
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Estrogen receptor α and β in uterine fibroids: a basis for altered estrogen responsivenessFertility and Sterility, 2008
- Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptorCancer Chemotherapy and Pharmacology, 2008
- Metabolic Actions of Estrogen Receptor Beta (ERβ) are Mediated by a Negative Cross-Talk with PPARγPLOS Genetics, 2008
- The Effect of Repeated Administration of Cyclophosphamide on Cytochrome P450 2B in RatsClinical Cancer Research, 2007
- Estrogen Receptor-β: Recent Lessons from in Vivo StudiesMolecular Endocrinology, 2007
- Loss of ERβ expression as a common step in estrogen-dependent tumor progressionEndocrine-Related Cancer, 2004
- Involvement of Estrogen Receptor β in Ovarian CarcinogenesisCancer Research, 2004
- Differential expression of the estrogen receptor beta (ERβ) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinomaThe Prostate, 2002
- Biphasic Regulation of Breast Cancer Cell Growth by Progesterone: Role of the Cyclin-Dependent Kinase Inhibitors, p21 and p27Kip1Molecular Endocrinology, 1997
- AN OVARIAN HORMONEJAMA, 1923